Harnessing the Power of Real-World Data to Drive More Effective Decision Making in Oncology Clinical Trials

This article explores the field of NH studies, explaining what they are and how they can be used to build faster, more efficient, patient-centric trials with a better chance of success and approval, both for rare diseases and the wider drug development market.